{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:49:21Z","timestamp":1791071361032,"version":"4.1.0"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:named-content content-type=\"genus-species\">Candida africana<\/jats:named-content>\n            was previously proposed as a new species within the\n            <jats:named-content content-type=\"genus-species\">Candida albicans<\/jats:named-content>\n            species complex, together with\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            and\n            <jats:named-content content-type=\"genus-species\">C. dubliniensis<\/jats:named-content>\n            , although further phylogenetic analyses better support its status as an unusual variant within\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            . Here we show that\n            <jats:named-content content-type=\"genus-species\">C. africana<\/jats:named-content>\n            can be distinguished from\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            and\n            <jats:named-content content-type=\"genus-species\">C. dubliniensis<\/jats:named-content>\n            by pyrosequencing of a short region of ITS2, and we have evaluated its occurrence in clinical samples by pyrosequencing all presumptive isolates of\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            submitted to the Mycology Reference Laboratory over a 9-month period. The\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            complex constituted 826\/1,839 (44.9%) of yeast isolates received over the study period and included 783 isolates of\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            , 28 isolates of\n            <jats:named-content content-type=\"genus-species\">C. dubliniensis<\/jats:named-content>\n            , and 15 isolates of\n            <jats:named-content content-type=\"genus-species\">C. africana<\/jats:named-content>\n            . In agreement with previous reports,\n            <jats:named-content content-type=\"genus-species\">C. africana<\/jats:named-content>\n            was isolated exclusively from genital specimens, in women in the 18-to-35-year age group. Indeed,\n            <jats:named-content content-type=\"genus-species\">C. africana<\/jats:named-content>\n            constituted 15\/251 (6%) of \u201c\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            \u201d isolates from female genital specimens during the study period.\n            <jats:named-content content-type=\"genus-species\">C. africana<\/jats:named-content>\n            isolates were germ tube positive, grew significantly more slowly than\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            and\n            <jats:named-content content-type=\"genus-species\">C. dubliniensis<\/jats:named-content>\n            on conventional mycological media, could be distinguished from the other members of the\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            complex by appearance on chromogenic agar, and were incapable of forming chlamydospores. Here we present the detailed evaluation of epidemiological, phenotypic, and clinical features and antifungal susceptibility profiles of United Kingdom isolates of\n            <jats:named-content content-type=\"genus-species\">C. africana<\/jats:named-content>\n            . Furthermore, we demonstrate that\n            <jats:named-content content-type=\"genus-species\">C. africana<\/jats:named-content>\n            is significantly less pathogenic than\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            and\n            <jats:named-content content-type=\"genus-species\">C. dubliniensis<\/jats:named-content>\n            in the\n            <jats:named-content content-type=\"genus-species\">Galleria mellonella<\/jats:named-content>\n            insect systemic infection model.\n          <\/jats:p>","DOI":"10.1128\/jcm.02816-12","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T04:55:40Z","timestamp":1357793740000},"page":"967-972","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":85,"title":["Epidemiology, Antifungal Susceptibility, and Pathogenicity of Candida africana Isolates from the United Kingdom"],"prefix":"10.1128","volume":"51","author":[{"given":"Andrew M.","family":"Borman","sequence":"first","affiliation":[{"name":"UK National Mycology Reference Laboratory (MRL), Health Protection Agency South-West, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Szekely","sequence":"additional","affiliation":[{"name":"UK National Mycology Reference Laboratory (MRL), Health Protection Agency South-West, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chistopher J.","family":"Linton","sequence":"additional","affiliation":[{"name":"UK National Mycology Reference Laboratory (MRL), Health Protection Agency South-West, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Palmer","sequence":"additional","affiliation":[{"name":"UK National Mycology Reference Laboratory (MRL), Health Protection Agency South-West, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipa","family":"Brown","sequence":"additional","affiliation":[{"name":"UK National Mycology Reference Laboratory (MRL), Health Protection Agency South-West, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"UK National Mycology Reference Laboratory (MRL), Health Protection Agency South-West, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"9","article-title":"Invasive Candida infections: the changing epidemiology","volume":"18","author":"Marr KA","year":"2004","unstructured":"MarrKA. 2004. Invasive Candida infections: the changing epidemiology. Oncology 18(14 Suppl 13):9\u201314.","journal-title":"Oncology"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/432060"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0732-8893(99)00046-2","article-title":"International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participaant Group (Europe)","volume":"35","author":"Pfaller MA","year":"1999","unstructured":"PfallerMA JonesRN DoernGV FluitAC VerhoefJ SaderHS MesserSA HoustonA CoffmanS HollisRJ. 1999. International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participaant Group (Europe). Diagn. Microbiol. Infect. Dis. 35:19\u201325.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(97)00240-X"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2174\/138945006776359421"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.5_suppl.500S"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.Supplement_1.S49"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70363-9"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00242-10"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-141-7-1507"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032952"},{"key":"e_1_3_2_13_2","first-page":"15","article-title":"Candida dubliniensis: an emerging opportunistic pathogen","volume":"8","author":"Sullivan DJ","year":"1997","unstructured":"SullivanDJ ColemanDC. 1997. Candida dubliniensis: an emerging opportunistic pathogen. Curr. Top. Med. Mycol. 8:15\u201325.","journal-title":"Curr. Top. Med. Mycol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsle.2005.09.015"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-1356(03)00240-X"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/205921"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2009.01833.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/fgbi.1999.1164"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.9.2462-2465.1995"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780701633101"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1567-1364.2008.00392.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2008.01630.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2010.01939.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2001.00707.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2008.05.014"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01540-08"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.3.821-823.1999"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01071-10"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00240-09"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02116-07"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780500179678"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02061-06"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-010-9284-7"},{"key":"e_1_3_2_34_2","volume-title":"Reference method for broth dilution susceptibility testing of yeasts: approved standard","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution susceptibility testing of yeasts: approved standard, 3rd ed. Document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"3"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2000.tb01427.x"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-539-8_33"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2010.03.001"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.4161\/viru.1.6.12985"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00041-07"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.4.1599-1608.2000"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-11-247"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.662598"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2004.05.008"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.4161\/viru.2.1.15002"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2475"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fgb.2006.11.014"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.40.3.249.257"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02816-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02816-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T11:36:17Z","timestamp":1646480177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.02816-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1128\/JCM.02816-12"],"URL":"https:\/\/doi.org\/10.1128\/jcm.02816-12","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"2012-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-01-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}